SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Tammy
Lv4
570 积分
2021-01-25 加入
最近求助
最近应助
互助留言
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era
9天前
已完结
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: subgroup analyses from the phase 4 BYOND study
12天前
已完结
What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia
24天前
已完结
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA)
1个月前
已完结
Transcriptome- and metabolome-based candidate mechanism of BCR-ABL-independent resistance to olverembatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia
1个月前
已完结
Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome–positive acute lymphoblastic leukemia: two-case report
1个月前
已完结
Tyrosine kinase inhibitors combined with venetoclax and azacytidine as an effective therapy for de novo lymphoid blast phase-chronic myeloid leukemia
1个月前
已完结
Olverembatinib in relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a study of 5 cases
1个月前
已完结
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
1个月前
已完结
When to Stop TKIs in Patients with Chronic Myeloid Leukemia and How to Follow Them Subsequently
2个月前
已完结
没有进行任何应助
点赞
5个月前
抱歉,我求助的不是原文,是补充材料
5个月前
感谢
1年前
点赞,速度真快,感谢
2年前
感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论